Treasury Chief Reeves Plans Targeted Measures on Household Expenses in Upcoming Financial Plan

Chancellor Rachel Reeves has announced she is planning "focused action to deal with cost of living issues" in the forthcoming financial statement.

During an interview with the BBC, she emphasized that lowering price rises is a shared duty of both the government and the Bank of England.

The UK's inflation rate is expected to be the highest among the Group of Seven developed nations this year and next.

Possible Utility Cost Measures

It is understood the administration could take action to bring down utility costs, for instance by cutting the present 5% rate of value-added tax charged on energy supplies.

A further option is to reduce some of the policy costs presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will receive the latest report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for such actions.

The view from most experts is that the Chancellor will have to announce tax increases or expenditure reductions in order to fulfill her self-imposed borrowing rules.

Previously on the same day, estimates indicated there was a £22bn shortfall for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a collective responsibility between the central bank and the government to bear down further on some of the sources of price increases," Reeves stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Concerns

While much of the attention has been on probable tax increases, the chancellor said the most recent data from the fiscal watchdog had not changed her vow to election pledges not to raise tax levels on income tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with increasing international and trade tensions for the fiscal revenue measures, likely to be focused on those "most able to pay."

Global Trade Disputes

Referring to concerns about the United Kingdom's economic relations with China she said: "The UK's security interests always are paramount."

Last week's declaration by Chinese authorities to tighten export controls on critical minerals and other resources that are essential for high-technology production led US President Donald Trump to suggest an additional 100% tariff on imports from China, increasing the risk of an all-out trade war between the two global powers.

The American finance chief labeled China's decision "commercial pressure" and "a global supply chain control attempt."

Asked about considering the US offer to join its dispute with China, the Chancellor said she was "very concerned" by China's actions and encouraged the Chinese government "not to put up barriers and restrict access."

She said the decision was "damaging for the world economy and causes further challenges."

"It is my opinion there are fields where we must address Chinese policies, but there are also significant chances to sell into Chinese markets, including financial services and other areas of the economic system. We've got to achieve that equilibrium right."

The chancellor also confirmed she was cooperating with G7 counterparts "regarding our own essential resources strategy, so that we are reduced dependence."

NHS Medicine Pricing and Investment

Reeves also recognized that the price the National Health Service pays for drugs could increase as a result of ongoing discussions with the US government and its drugs companies, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either halting or canceling operations in the UK, with several blaming the insufficient payments they are receiving.

Recently, the Science Minister said the price the NHS spends on drugs would have to increase to prevent businesses and drug research funding leaving the United Kingdom.

Reeves told media: "We have seen because of the payment system, that drug testing, recent pharmaceuticals have not been available in the UK in the way that they are in other EU nations."

"The objective is to make sure that patients receiving care from the NHS are able to receive the best critical medicines in the world. And so we are reviewing all of that, and... aiming to secure additional investment into the UK."